瞳孔計の世界市場：洞察、競合情勢、市場予測：2030年

世界の瞳孔計の市場規模は、2023年に3億5,171万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に7.14%のCAGRで拡大し、2030年には5億2,944万米ドルに達すると予測されています。瞳孔計の需要は主に、脳損傷、脳腫瘍、脳卒中、ホルナー症候群などの神経疾患や様々な眼科疾患の症例が世界的に増加していることが後押ししています。さらに、先進的で革新的な技術の採用の増加、集中治療室の数の増加、先進的な製品の頻繁な発売と承認などが、2024年から2030年までの予測期間における瞳孔計市場の全体的な成長に寄与しています。

瞳孔計市場は、外傷性脳損傷、緑内障、その他のような様々な神経学的または眼科疾患の有病率の上昇などの様々な要因のために、製品需要の積極的な成長を示しています。

重度の脳損傷では、外傷性脳損傷時に機能不全に陥る自律神経系によって制御されている瞳孔の大きさや反応性に異常が生じることが多くなります。また、瞳孔の大きさが不均等である異所性瞳孔や、脳の腫れや出血、あるいはその両方が原因となる頭蓋内圧（ICP）の上昇も脳損傷と関連しており、瞳孔の大きさや反応性の異常を測定するために瞳孔計の使用が必要となります。

このように、瞳孔検査は脳損傷の重症度判定にも役立つため、脳損傷の評価や患者の経過観察における診断ツールとして使用することができます。今後、外傷性脳損傷の症例が増加することで、予測期間中の需要が増加する可能性があります。

当レポートでは、世界の瞳孔計市場について調査し、市場の概要とともに、モダリティ別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 瞳孔計市場レポートのイントロダクション

第2章 瞳孔計市場のエグゼクティブサマリー

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 瞳孔計市場の主な要因分析

• 瞳孔計市場の促進要因
• 瞳孔計市場の抑制要因と課題
• 瞳孔計市場の機会

第5章 瞳孔計市場におけるポーターのファイブフォース分析

第6章 瞳孔計市場概要

• モダリティ別
• 用途別
• エンドユーザー別
• 地域別

第7章 瞳孔計市場の企業と製品プロファイル

• NeurOptics, Inc
• IDMED
• Essilor Instruments USA
• Reichert, Inc.
• Gulden Ophthalmics
• iVIS Technologies
• NIDEK CO., LTD.
• AddVision Sweden
• Adaptica
• Johnson & Johnson Vision
• Alcon Vision LLC
• Chongqing Yeasn Science & Technology Co. Ltd
• BioMedix Optotechnik & Devices Pvt. Ltd.
• Mediworks
• Visionix
• Takagi Seiko Co., LTD.

第8章 KOL の見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightについて

第11章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Pupillometer Market in Global (2021-2030)
• Table 3: Pupillometer Market in Global by Modality (2021-2030)
• Table 4: Pupillometer Market in Global by Application (2021-2030)
• Table 5: Pupillometer Market in Global by End-User (2021-2030)
• Table 6: Pupillometer Market in Global by Geography (2021-2030)
• Table 7: Pupillometer Market in North America (2021-2030)
• Table 8: Pupillometer Market in the US (2021-2030)
• Table 9: Pupillometer Market in Canada (2021-2030)
• Table 10: Pupillometer Market in Mexico (2021-2030)
• Table 11: Pupillometer Market in Europe (2021-2030)
• Table 12: Pupillometer Market in France (2021-2030)
• Table 13: Pupillometer Market in Germany (2021-2030)
• Table 14: Pupillometer Market in the United Kingdom (2021-2030)
• Table 15: Pupillometer Market in Italy (2021-2030)
• Table 16: Pupillometer Market in Spain (2021-2030)
• Table 17: Pupillometer Market in the Rest of Europe (2021-2030)
• Table 18: Pupillometer Market in Asia-Pacific (2021-2030)
• Table 19: Pupillometer Market in China (2021-2030)
• Table 20: Pupillometer Market in Japan (2021-2030)
• Table 21: Pupillometer Market in India (2021-2030)
• Table 22: Pupillometer Market in Australia (2021-2030)
• Table 23: Pupillometer Market in South Korea (2021-2030)
• Table 24: Pupillometer Market in Rest of Asia-Pacific (2021-2030)
• Table 25: Pupillometer Market in the Rest of the World (2021-2030)
• Table 26: Pupillometer Market in the Middle East (2021-2030)
• Table 27: Pupillometer Market in Africa (2021-2030)
• Table 28: Pupillometer Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Pupillometer Market in Global (2021-2030)
• Figure 3: Pupillometer Market in Global by Modality (2021-2030)
• Figure 4: Pupillometer Market in Global by Application (2021-2030)
• Figure 5: Pupillometer Market in Global by End-User (2021-2030)
• Figure 6: Pupillometer Market in Global by Geography (2021-2030)
• Figure 7: Pupillometer Market in North America (2021-2030)
• Figure 8: Pupillometer Market in the US (2021-2030)
• Figure 9: Pupillometer Market in Canada (2021-2030)
• Figure 10: Pupillometer Market in Mexico (2021-2030)
• Figure 11: Pupillometer Market in Europe (2021-2030)
• Figure 12: Pupillometer Market in France (2021-2030)
• Figure 13: Pupillometer Market in Germany (2021-2030)
• Figure 14: Pupillometer Market in the United Kingdom (2021-2030)
• Figure 15: Pupillometer Market in Italy (2021-2030)
• Figure 16: Pupillometer Market in Spain (2021-2030)
• Figure 17: Pupillometer Market in the Rest of Europe (2021-2030)
• Figure 18: Pupillometer Market in Asia-Pacific (2021-2030)
• Figure 19: Pupillometer Market in China (2021-2030)
• Figure 20: Pupillometer Market in Japan (2021-2030)
• Figure 21: Pupillometer Market in India (2021-2030)
• Figure 22: Pupillometer Market in Australia (2021-2030)
• Figure 23: Pupillometer Market in South Korea (2021-2030)
• Figure 24: Pupillometer Market in the Rest of Asia-Pacific (2021-2030)
• Figure 25: Pupillometer Market in the Rest of the World (2021-2030)
• Figure 26: Pupillometer Market in the Middle East (2021-2030)
• Figure 27: Pupillometer Market in Africa (2021-2030)
• Figure 28: Pupillometer Market in South America (2021-2030)
• Figure 29: Market Drivers
• Figure 30: Market Barriers
• Figure 31: Marker Opportunities
• Figure 32: PORTER'S Five Force Analysis

The Pupillometer Market By Modality (Portable And Non-Portable), Application (Ophthalmology, Neurology, And Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of various neurological ophthalmic diseases and the increasing awareness associated with pupillometers and it's use across the globe

The global pupillometer market was valued at USD 351.71 million in 2023, growing at a CAGR of 7.14% during the forecast period from 2024 to 2030 to reach USD 529.44 million by 2030. The demand for pupillometers is primarily being boosted due to the increasing cases of neurological disorders such as brain injury, brain tumor, stroke, horner's syndrome, and others, and various ophthalmic disorders, globally. Further, the rising adoption of advanced and innovative technologies, the rising number of intensive care units, the frequent launches and approvals of advanced products, and others are thereby contributing to the overall growth of the pupillometer market during the forecast period from 2024-2030.

Pupillometer Market Dynamics:

The pupillometer market is witnessing a positive growth in product demand owing to various factors such as an increase in the prevalence of various neurology or ophthalmic disorders like traumatic brain injury, glaucoma, and others.

According to the Centers for Disease Control and Prevention (CDC) April 2023, there were approximately 69,473 traumatic brain injury (TBI) related hospitalizations in 2021, in the US. Severe brain injuries often result in abnormal pupil size and reactivity which are controlled by the autonomic nervous system, which can get malfunctioned during traumatic brain injuries. The other condition such as anisocoric, a condition where the pupils are unequal in size and increased intracranial pressure (ICP), which can be a result of brain swelling or bleeding or both are also associated with brain injury in which the use of pupillometry is required for measuring abnormal pupil size and reactivity.

Thus, pupillometry can be used as a diagnostic tool in assessing brain injury and monitoring the progress of patients, as it can also help in determining the severity of a brain injury. Henceforth, the increasing cases of traumatic brain injury may increase the demand during the forecast period.

Furthermore, the increasing cases of glaucoma, a progressive eye disease causing optic nerve damage, can increase the demand for pupilometers. For instance, according to CDC 2022, glaucoma is one of the leading causes of irreversible blindness in the United States. The source stated that by 2050, cases of glaucoma are expected to reach 6.3 million, in the US. Currently, there is no cure for glaucoma. But if the disease is found early, it can be treated and managed before vision loss or blindness occurs.

As there are usually no symptoms, only 50% of people with glaucoma even know they have it. The pupillometry can aid in the early detection and monitoring of glaucoma, allowing for timely intervention. It provides objective measurements of pupillary responses, helping assess disease severity and evaluate treatment effectiveness. Therefore, the increasing cases of glaucoma may need to use pupillometry for early diagnosis and timely intervention. Thus, the increasing cases of glaucoma may increase the demand for pupillometry devices in the upcoming years.

Thereby, the aforementioned factors will propel the overall market growth of pupillometer during the forecast period from 2024-2030.

However, the presence of alternative devices among others may restrict the pupillometer market growth.

Pupillometer Market Segment Analysis:

Pupillometer Market by Modality (Portable and Non-Portable), Application (Ophthalmology, Neurology, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the modality segment of the pupillometer, the portable device is expected to grow during the forecast period. This can be ascribed to the advantages offered by portable pupillometry.

Portable pupillometry is utilized in surgery for several purposes and indications as it helps in monitoring anesthesia depth, ensuring appropriate levels of sedation during any surgical procedure, and detecting any intraoperative complications that may affect pupil function. Pupillometry also allows for the evaluation of immediate postoperative outcomes and the identification of any changes in pupil function that may require further investigation or intervention.

Portable pupillometry is s a convenient tool for anesthesia providers and surgical teams to assess pupil responses and make immediate adjustments during the procedure, especially in situations where non-portable devices are not readily available, such as during inpatient surgery.

For instance, according to the World Health Organization (WHO) 2022, nearly 8,529,608 cases of total inpatient surgery were done in Russia in 2021. In such cases, a pupilometer can be used to monitor different parameters such as anesthesia depth, sedation levels, hemorrhagic stroke, and cerebral edema, among others. Therefore, the rising utilization of portable pupillometry during surgeries for evaluating postoperative outcomes will increase its demand in the market.

Also, portable pupillometry devices offer the advantage of mobility and ease of use in various settings, including the operating room. Portable devices are smaller, handheld, and often more accessible, allowing for real-time pupil measurements during surgery. Overall, the demand for potable pupillometry devices in surgical settings is driven positively for enhanced patient safety, improved outcomes, and others.

Thus, the above-mentioned factors and the advantages offered by portable devices over others are predicted to contribute to the increasing demand for this segment type, thereby propelling the overall market of pupillometers during the upcoming years.

North America is expected to dominate the overall Pupillometer Market:

Among all the regions, North America is estimated to account for the largest share of the pupillometer market in the year 2023. Owing to the significance of key growth factors such as the increasing cases of brain tumors, stroke, glaucoma, retinal, cerebral vascular disease, amblyopia, and others are thereby driving the North American pupillometer market in the forthcoming years. Furthermore, the increasing old age population prone to neurological or ophthalmic diseases, the high disposable income, the sophisticated healthcare infrastructure, the rising number of working hours, the high awareness about eye diagnosis, and others will also help the market growth in this region.

Brain tumors can affect pupillometry by exerting pressure on cranial nerves, leading to changes in pupil size and reactivity. Tumors located near the brainstem or base of the skull can compress the cranial nerves responsible for controlling the pupils, resulting in dilation or constriction of the pupil. Additionally, brain tumors can increase intracranial pressure, causing pupil dilation or sluggish response. Brain tumors can also disrupt the autonomic nervous system, which regulates pupil function.

For instance, according to the National Brain Tumor Society (2023), estimated that 94,390 Americans will receive a primary brain tumor diagnosis in 2023, in the US. However, as the population increases, the overall number of individuals at risk for developing brain tumors may also rise. Pupillometry is used alongside other diagnostic methods to assess the impact of brain tumors on neurological function. Thus, the increasing cases of brain tumors may also increase the demand for pupillometry devices in a region.

Furthermore, a stroke occurs when the blood supply to the brain is disrupted, leading to damage in that area. This can affect the nerves that control the pupils, the black circular openings in the eyes. As a result, a stroke can cause changes in pupil size or reactivity. These changes may include unequal pupil sizes (anisocoria), constricted pupils (miosis), dilated pupils (mydriasis), or sluggish/non-reactive pupils. For instance, according to CDC 2023, every 40 seconds, someone in the United States has a stroke. Every year, more than 795,000 people in the United States have a stroke. About 610,000 of these are first or new strokes and about 185,000 strokes, nearly 1 in 4 are in people who have had a previous stroke. Therefore, pupilometry provides objective and quantitative data that can aid in the early detection of complications and assist in assessing the progression of complications related to stroke.

Pupilometry plays a crucial role in the comprehensive evaluation and care of stroke patients, contributing to better outcomes and more targeted treatment approaches. Thus, the increasing number of cases of stroke in the region may increase the demand for pupilometry.

Therefore, the aforementioned factors would provide a positive growth environment for the North American region in the pupillometer device market.

Pupillometer Market Key Players:

Some of the key market players operating in the pupillometer market include NeurOptics, Inc., IDMED, Essilor Instruments USA, Reichert, Inc., Gulden Ophthalmics, iVIS Technologies, NIDEK CO., LTD., AddVision Sweden, Adaptica, Johnson & Johnson Vision, Alcon Vision LLC, Chongqing Yeasn Science & Technology Co. Ltd, BioMedix Optotechnik & Devices Pvt. Ltd., Mediworks, Visionix, Takagi Seiko Co., LTD., and others.

Recent Developmental Activities in the Pupillometer Market:

In May 2022, NeurOptics Inc., launched NPi-300 pupillometer in 15 countries. Some of the countries where the pupillometer was launched include the United Kingdom, France, Italy, Germany, Switzerland, Austria, Norway, Sweden, Denmark, Belgium, the Netherlands, Luxembourg, Ireland, Australia, and New Zealand.

In July 2021, NeurOptics launched NPi®-300 Automated Pupillometer. The device is a handheld optical scanner that measures pupil size and reactivity in patients, supporting enhanced neurological pupillary examinations to diagnose a broad spectrum of neurological conditions such as traumatic brain injuries, strokes, and seizures in adult and pediatric patients.

Key Takeaways from the Pupillometer Market Report Study

Market size analysis for current pupillometer market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global pupillometer market.

Various opportunities are available for the other competitor in the pupillometer market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current pupillometer market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for pupillometer market growth in the coming future?

Target Audience who can be benefited from this Pupillometer Market Report Study

Pupillometer device products providers

Research organizations and consulting companies

Pupillometer-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in pupillometer

Various End-users who want to know more about the pupillometer market and the latest technological developments in the pupillometer market.

Frequently Asked Questions for the Pupillometer Market:

1. What is a pupillometer?

A pupillometer is a specialized instrument used to measure and analyze pupillary responses. It consists of a light source, sensors, or cameras to capture images or videos of the eyes and software for data analysis. Pupillometry measurements provide information about the size, shape, and reactivity of the pupils which might detect ophthalmic disease and neurological disorders.

2. What is the market for global pupillometer?

The global pupillometer market was valued at USD 351.71 million in 2023, growing at a CAGR of 7.14% during the forecast period from 2024 to 2030 to reach USD 529.44 million by 2030.

3. What are the drivers for the global pupillometer market?

The demand for pupillometers is primarily being boosted by the increasing prevalence of ophthalmic diseases such as glaucoma, horner's syndrome, and others. In addition, the surging incidence of neurological disorders, the increasing technological advancements, the rising awareness about eye diseases and their diagnosis, the rising product launches and approvals, and others thereby contribute to the overall growth of the pupillometer market during the forecast period from 2024-2030.

4. Who are the key players operating in the global pupillometer market?

Some of the key market players operating in the pupillometer market include NeurOptics, Inc., IDMED, Essilor Instruments USA, Reichert, Inc., Gulden Ophthalmics, iVIS Technologies, NIDEK CO., LTD., AddVision Sweden, Adaptica, Johnson & Johnson Vision, Alcon Vision LLC, Chongqing Yeasn Science & Technology Co. Ltd, BioMedix Optotechnik & Devices Pvt. Ltd., Mediworks, Visionix, Takagi Seiko Co., LTD., and others.

5. Which region has the highest share in the pupillometer market?

North America is expected to dominate the overall pupillometer market during the forecast period from 2022-2028. Owing to the factors such as the rising prevalence of neurological disorders such as tumors, stroke, coma, traumatic brain injury, and others, increasing inpatient surgery cases, rising burden of ophthalmic disorders, and others will increase the North American pupillometer market. Furthermore, high disposable income, sophisticated healthcare infrastructure, high awareness about eye diseases and their diagnosis, and others will also help the market growth in this region.

Table of Contents

1.Pupillometer Market Report Introduction

2. Pupillometer Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Pupillometer Market Key Factors Analysis

• 4.1. Pupillometer Market Drivers
  • 4.1.1. Rising prevalence of ophthalmic and neurological disorders
  • 4.1.2. Increasing demand for pupillary assessment and other diagnostic tools among the end-users owing to rising awareness about ophthalmic disorders
• 4.2. Pupillometer Market Restraints and Challenges
  • 4.2.1. Presence of alternative devices
• 4.3. Pupillometer Market Opportunities
  • 4.3.1. Increasing technological advancements such as sensor technology, eye tracking system, augmented reality (AR), and virtual reality (VR)

5. Pupillometer Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. The threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. Pupillometer Market Layout

• 6.1. By Modality
  • 6.1.1. Portable
  • 6.1.2. Non-portable
• 6.2. Application
  • 6.2.1. Ophthalmology
  • 6.2.2. Neurology
  • 6.2.3. Others
• 6.3. End-User
  • 6.3.1. Hospitals & Clinics
  • 6.3.2. Ambulatory surgical centers
  • 6.3.3. Others
• 6.4. By Geography
  • 6.4.1. North American Pupillometer Market Size in USD million (2021-2030)
    • 6.4.1.1. The United States Pupillometer Market Size in USD million (2021-2030)
    • 6.4.1.2. Canada Pupillometer Market Size in USD million (2021-2030)
    • 6.4.1.3. Mexico Pupillometer Market Size in USD million (2021-2030)
  • 6.4.2. Europe Pupillometer Market Size in USD million (2021-2030)
    • 6.4.2.1. France Pupillometer Market Size in USD million (2021-2030)
    • 6.4.2.2. Germany Pupillometer Market Size in USD million (2021-2030)
    • 6.4.2.3. The United Kingdom Pupillometer Market Size in USD million (2021-2030)
    • 6.4.2.4. Italy Pupillometer Market Size in USD million (2021-2030)
    • 6.4.2.5. Spain Pupillometer Market Size in USD million (2021-2030)
    • 6.4.2.6. Rest of Europe Pupillometer Market Size in USD million (2021-2030)
  • 6.4.3. Asia-Pacific Pupillometer Market Size in USD million (2021-2030)
    • 6.4.3.1. China Pupillometer Market Size in USD million (2021-2030)
    • 6.4.3.2. Japan Pupillometer Market Size in USD million (2021-2030)
    • 6.4.3.3. India Pupillometer Market Size in USD MILLION (2021-2030)
    • 6.4.3.4. Australia Pupillometer Market Size in USD million (2021-2030)
    • 6.4.3.5. South Korea Pupillometer Market Size in USD million (2021-2030)
    • 6.4.3.6. Rest of the Asia-Pacific Pupillometer Market Size in USD million (2021-2030)
  • 6.4.4. Rest of the World (RoW) Pupillometer Market Size in USD million (2021-2030)
    • 6.4.4.1. Middle East Coronary Guidewire Market Size in USD Million (2021-2030)
    • 6.4.4.2. Africa Coronary Guidewire Market Size in USD Million (2021-2030)
    • 6.4.4.3. South America Coronary Guidewire Market Size in USD Million (2021-2030)

7. Pupillometer Market Company and Product Profiles

• 7.1. NeurOptics, Inc.
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2. IDMED
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3. Essilor Instruments USA
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4. Reichert, Inc.
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5. Gulden Ophthalmics
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6. iVIS Technologies
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7. NIDEK CO., LTD.
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8. AddVision Sweden
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy
• 7.9. Adaptica
  • 7.9.1. Company Overview
  • 7.9.2. Company Snapshot
  • 7.9.3. Financial Overview
  • 7.9.4. Product Listing
  • 7.9.5. Entropy
• 7.10. Johnson & Johnson Vision
  • 7.10.1. Company Overview
  • 7.10.2. Company Snapshot
  • 7.10.3. Financial Overview
  • 7.10.4. Product Listing
  • 7.10.5. Entropy
• 7.11. Alcon Vision LLC
  • 7.11.1. Company Overview
  • 7.11.2. Company Snapshot
  • 7.11.3. Financial Overview
  • 7.11.4. Product Listing
  • 7.11.5. Entropy
• 7.12. Chongqing Yeasn Science & Technology Co. Ltd
  • 7.12.1. Company Overview
  • 7.12.2. Company Snapshot
  • 7.12.3. Financial Overview
  • 7.12.4. Product Listing
  • 7.12.5. Entropy
• 7.13. BioMedix Optotechnik & Devices Pvt. Ltd.
  • 7.13.1. Company Overview
  • 7.13.2. Company Snapshot
  • 7.13.3. Financial Overview
  • 7.13.4. Product Listing
  • 7.13.5. Entropy
• 7.14. Mediworks
  • 7.14.1. Company Overview
  • 7.14.2. Company Snapshot
  • 7.14.3. Financial Overview
  • 7.14.4. Product Listing
  • 7.14.5. Entropy
• 7.15. Visionix
  • 7.15.1. Company Overview
  • 7.15.2. Company Snapshot
  • 7.15.3. Financial Overview
  • 7.15.4. Product Listing
  • 7.15.5. Entropy
• 7.16. Takagi Seiko Co., LTD.
  • 7.16.1. Company Overview
  • 7.16.2. Company Snapshot
  • 7.16.3. Financial Overview
  • 7.16.4. Product Listing
  • 7.16.5. Entropy

8. KOL Views

9. Project Approach

10. About DelveInsight

11. Disclaimer & Contact Us